For the Inventor, By the Inventor

Enter inventor name

Ridgefield, CT, United States of America

Xudong Wei

USPTO Granted Patents = 20 (Patent Applications = 3)

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 8)

Average Co-Inventor Count = 7.1

ph-index = 7

Forward Citations = 111(Granted Patents)

Location History:

Ridgefield, CT (US) (2006 - 2017)
Coventry, RI (US) (2020)

Company Filing History:

18 out of 1,535

Boehringer Ingelheim International Gmbh

Boehringer Ingelheim Pharmaceuticals, Inc.

Years Active: 2006-2020

where 'Filed Patents' based on already Granted Patents

20 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 10745411 - Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma (2020-08-18),

2. 9802954 - Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma (2017-10-31),

3. 9150586 - Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma (2015-10-06),

4. 9096626 - Monophosphorus ligands and their use in cross-coupling reactions (2015-08-04),

5. 8975405 - Indenopyridine derivatives (2015-03-10),

6. 8946418 - Chiral nitrogen-phosphorus ligands and their use for asymmetric hydrogenation of alkenes (2015-02-03),

7. 8735585 - Indenopyridine derivatives (2014-05-27),

8. 8633320 - Process for preparing bromo-substituted quinolines (2014-01-21),

9. 8609670 - Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma (2013-12-17),

10. 8552212 - Chiral phosphorus ligands (2013-10-08),

11. 8222369 - Process for preparing macrocyclic compounds (2012-07-17),

12. 8101765 - Process for preparing acyclic HCV protease inhibitors (2012-01-24),

13. 8017771 - Process for preparing acyclic HCV protease inhibitors (2011-09-13),

14. 7608614 - Process for preparing macrocyclic compounds (2009-10-27),

15. 7550622 - Cycloalkylamidoacid compounds, processes for making and uses thereof (2009-06-23),

Title: Profile of Xudong Wei: Innovator in Pharmaceutical Patents

Introduction

Xudong Wei, based in Ridgefield, CT, is an accomplished inventor with a remarkable portfolio of 20 patents. His innovations primarily focus on pharmaceuticals, contributing significantly to the treatment of respiratory conditions.

Latest Patents

Among his notable inventions is a patent for Piperidino-dihydrothienopyrimidine sulfoxides, which are utilized for treating Chronic Obstructive Pulmonary Disease (COPD) and asthma. This invention showcases his commitment to addressing critical health challenges through innovative medical solutions.

Career Highlights

Xudong Wei has made significant strides in his career while working with leading companies such as Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals, Inc. His experience in these prestigious organizations has undoubtedly shaped his inventive journey.

Collaborations

Throughout his career, Wei has collaborated with notable professionals, including Chris Hugh Senanayake and Nizar Haddad. These collaborations have likely fostered a rich exchange of ideas and expertise, further enhancing his contributions to the field.

Conclusion

Xudong Wei's innovative work and extensive patent portfolio underscore his significant impact on the pharmaceutical industry. His dedication to improving health outcomes through inventions positions him as a key player in respiratory treatment developments.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…